A detailed history of Oregon Public Employees Retirement Fund transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 174,079 shares of BMY stock, worth $9.26 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
174,079
Previous 173,922 0.09%
Holding current value
$9.26 Million
Previous $9.43 Million 23.35%
% of portfolio
0.15%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $6,319 - $8,319
157 Added 0.09%
174,079 $7.23 Million
Q1 2024

May 02, 2024

SELL
$47.98 - $54.4 $8.35 Million - $9.46 Million
-173,979 Reduced 50.01%
173,922 $9.43 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $5.03 Million - $6.01 Million
-103,849 Reduced 22.99%
347,901 $17.9 Million
Q3 2023

Oct 26, 2023

SELL
$57.89 - $64.73 $6.94 Million - $7.76 Million
-119,947 Reduced 20.98%
451,750 $26.2 Million
Q2 2023

Jul 26, 2023

SELL
$63.71 - $70.74 $11.9 Million - $13.2 Million
-186,265 Reduced 24.57%
571,697 $36.6 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $1.16 Million - $1.31 Million
-17,635 Reduced 2.27%
757,962 $52.5 Million
Q4 2022

Jan 26, 2023

SELL
$68.48 - $81.09 $361,711 - $428,317
-5,282 Reduced 0.68%
775,597 $0
Q3 2022

Nov 01, 2022

SELL
$0.13 - $76.84 $3,167 - $1.87 Million
-24,369 Reduced 3.03%
780,879 $55.5 Million
Q2 2022

Jul 25, 2022

BUY
$72.62 - $79.98 $14.8 Million - $16.3 Million
203,286 Added 33.77%
805,248 $62 Million
Q1 2022

Apr 21, 2022

SELL
$61.48 - $73.72 $2.97 Million - $3.56 Million
-48,302 Reduced 7.43%
601,962 $44 Million
Q4 2021

Feb 01, 2022

SELL
$53.63 - $62.52 $793,616 - $925,170
-14,798 Reduced 2.23%
650,264 $40.5 Million
Q3 2021

Oct 19, 2021

BUY
$59.17 - $69.31 $2.39 Million - $2.8 Million
40,459 Added 6.48%
665,062 $39.4 Million
Q2 2021

Jul 23, 2021

BUY
$61.91 - $67.42 $4.81 Million - $5.24 Million
77,703 Added 14.21%
624,603 $41.7 Million
Q1 2021

Apr 20, 2021

SELL
$59.34 - $66.74 $328,980 - $370,006
-5,544 Reduced 1.0%
546,900 $34.5 Million
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $10.2 Million - $11.6 Million
-177,385 Reduced 24.31%
552,444 $34.3 Million
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $2.84 Million - $3.15 Million
-49,500 Reduced 6.35%
729,829 $44 Million
Q2 2020

Jul 21, 2020

SELL
$54.82 - $64.09 $10.3 Million - $12 Million
-187,722 Reduced 19.41%
779,329 $45.8 Million
Q1 2020

Apr 20, 2020

BUY
$46.4 - $67.43 $27.1 Million - $39.4 Million
584,905 Added 153.06%
967,051 $53.9 Million
Q4 2019

Feb 05, 2020

BUY
$49.21 - $64.19 $1.39 Million - $1.82 Million
28,311 Added 8.0%
382,146 $24.5 Million
Q3 2019

Nov 07, 2019

SELL
$42.77 - $50.71 $388,351 - $460,446
-9,080 Reduced 2.5%
353,835 $17.9 Million
Q2 2019

Jul 16, 2019

BUY
$44.62 - $49.34 $8.56 Million - $9.47 Million
191,891 Added 112.2%
362,915 $16.5 Million
Q1 2019

May 07, 2019

SELL
$45.12 - $53.8 $295,716 - $352,605
-6,554 Reduced 3.69%
171,024 $8.16 Million
Q4 2018

Feb 07, 2019

SELL
$48.76 - $63.23 $441 Million - $572 Million
-9,052,926 Reduced 98.08%
177,578 $9.23 Million
Q4 2018

Feb 05, 2019

BUY
$48.76 - $63.23 $432 Million - $560 Million
8,850,072 Added 2326.32%
9,230,504 $178,000
Q3 2018

Oct 30, 2018

BUY
$55.19 - $62.25 $111,207 - $125,433
2,015 Added 0.53%
380,432 $23.6 Million
Q2 2018

Aug 13, 2018

SELL
$50.53 - $62.98 $1.27 Million - $1.58 Million
-25,104 Reduced 6.22%
378,417 $20.9 Million
Q1 2018

Apr 12, 2018

BUY
$59.92 - $68.98 $80,292 - $92,433
1,340 Added 0.33%
403,521 $25.5 Million
Q4 2017

Jan 11, 2018

BUY
$59.94 - $65.35 $347,292 - $378,637
5,794 Added 1.46%
402,181 $0
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $21.9 Million - $25.3 Million
396,387
396,387 $25.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.